Press "Enter" to skip to content

Elagolix for the management of heavy menstrual bleeding associated with uterine fibroids: results from a phase 2a proof-of-concept study

To evaluate the safety and efficacy of elagolix vs. placebo and elagolix with low-dose E2/progestogen add-back therapy.
Source: fertstert.org

Be First to Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.